CECR and BL-NCE funding extensions announced

The Networks of Centres of Excellence (NCE) secretariat has released the results of its competition to determine which of the original recipients of its two industry-facing programs will receive extended funding. The competition awarded renewed funding for four of the original 11 Centres of Excellence for Commercialization and Research (CECR) and one of the four Business-Led NCEs (BL-NCE). The successful CECRs are the Centre for Drug Research and Development (CDRD) ($8 million); Centre for Probe Development and Commercialization (CPDC) ($13.8 million); MaRS Innovation ($14.95 million); and, Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development (PC-TRIADD) ($11.33 million). The successful BL-NCE was the Quebec Consortium for Drug Discovery (CQDM), which will receive $11.7 million over five years. A full report will be in the next issue of RE$EARCH MONEY...